Login / Signup

Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).

Andrew J FisherMichael WhiteNicola GoudieAnneka KershawJulia PhillipsonMichelle BardgettJoanne LallyAlex Bevin-NichollsThomas ChadwickAndrew BryantSian RussellHesther SmithLaura FrisbyRebecca ErringtonMartin CarbyRichard ThompsonKarthik SanthanakrishnanJasvir ParmarJames L LordanLuke ValeHelen HancockCatherine ExleyAndrew R GenneryJames Ms Wason
Published in: BMJ open respiratory research (2024)
EudraCT number 2022-002659-20; ISRCTN 10615985.
Keyphrases
  • study protocol
  • open label
  • healthcare
  • clinical trial
  • randomized controlled trial
  • cross sectional
  • quality improvement
  • replacement therapy
  • double blind
  • phase ii study
  • smoking cessation
  • locally advanced
  • drug induced